GABELLI FUNDS LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 105 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$817,391
+832.8%
369,860
+972.1%
0.01%
+500.0%
Q1 2023$87,630
+21.7%
34,500
-10.4%
0.00%0.0%
Q4 2022$71,995
-41.0%
38,500
-18.9%
0.00%0.0%
Q3 2022$122,000
+32.6%
47,5000.0%0.00%0.0%
Q2 2022$92,000
-35.7%
47,500
-1.0%
0.00%0.0%
Q1 2022$143,000
-33.8%
48,0000.0%0.00%0.0%
Q4 2021$216,000
+3.3%
48,000
+11.6%
0.00%0.0%
Q3 2021$209,000
+207.4%
43,000
+330.0%
0.00%
Q2 2021$68,000
-34.0%
10,000
-31.5%
0.00%
-100.0%
Q1 2021$103,000
+21.2%
14,600
+7.4%
0.00%0.0%
Q4 2020$85,000
+34.9%
13,600
+17.2%
0.00%
Q3 2020$63,000
+3.3%
11,6000.0%0.00%
Q2 2020$61,000
+60.5%
11,600
-4.9%
0.00%
Q1 2020$38,000
-22.4%
12,2000.0%0.00%
Q4 2019$49,000
-73.9%
12,200
-72.0%
0.00%
-100.0%
Q3 2019$188,000
-4.1%
43,500
-11.2%
0.00%0.0%
Q2 2019$196,000
-32.2%
49,000
-9.3%
0.00%
-50.0%
Q1 2019$289,000
+4.3%
54,0000.0%0.00%0.0%
Q4 2018$277,00054,0000.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
AIGH Capital Management LLC 3,387,172$6,537,0001.72%
Worth Venture Partners, LLC 969,698$2,366,0001.39%
Omega Fund Management, LLC 1,971,241$3,804,0001.21%
Telemetry Investments, L.L.C. 495,000$955,0001.13%
CM Management, LLC 350,000$676,0000.72%
Bruce & Co., Inc. 1,557,312$3,005,0000.71%
Trellus Management Company, LLC 295,000$569,0000.69%
Abingworth LLP 1,041,131$1,999,0000.64%
1492 Capital Management LLC 489,376$944,0000.62%
GENERAL AMERICAN INVESTORS CO INC 1,752,470$3,382,0000.34%
View complete list of PARATEK PHARMACEUTICALS INC shareholders